<DOC>
	<DOCNO>NCT00211536</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness insulin deliver peritoneum ( abdomen ) implantable pump Type 1 diabetic .</brief_summary>
	<brief_title>Study Comparing Effectiveness Intraperitoneal Insulin Administration Subcutaneous Insulin Administration</brief_title>
	<detailed_description>Implantable insulin delivery pump show reduce occurrence severe hypoglycemia Type 1 DM subject , demonstrate numerous European study . Glycemic control difficult attain subject use exogenous insulin due risk severe hypoglycemia . This study aim compare efficacy intraperitoneal ( IP ) insulin therapy intensive subcutaneous insulin therapy period 12 month .</detailed_description>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Type 1 diabetes mellitus ( American Diabetes Association definition ) HbA1c great equal 7.5 % Intensive insulin treatment least 3 month Physical intellectual ability operate MIP system Subject routine care investigator least two month prior enrollment Subject reliable support person ( defined person daily contact subject know contact event emergency ) . Capability willingness perform selfmonitoring blood glucose least four time daily 9 month study 7 time daily 3 month study Physical intellectual ability operate MIP system comply data reporting requirement study . Subject willing sign inform consent form ( approved local Institutional Review Board Medtronic MiniMed ) The subject 's insulin usage exceed 66 unit per day . Severe complication advance autonomic neuropathy , legal blindness , symptomatic cardiovascular disease evidence cardiovascular episode within last six month Reside plan travel elevation 8000 foot study period ( commercial airline travel acceptable ) Subject pregnant , childbearing potential lactating neither surgically sterile , use contraceptive ( device , oral implant ) physician approve contraceptive The subject major concomitant disease physical psychological disorder within last five year , might consider life threaten , might confound collection interpretation study data The subject previously enrol participated investigational drug device study within precede 4 week The subject condition precludes him/her completing study requirement Has plan activity require go 25 foot sea level</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Implantable Insulin Pump</keyword>
	<keyword>Intraperitoneal Insulin Delivery</keyword>
</DOC>